非那雄胺 Finasteride × 雄性禿（雄性激素性脫髮）
結論：證據支持但有警示
Finasteride 1 mg/日治療男性雄性禿（AGA）為 S-tier 強證據：(1) 三項大型雙盲 RCT 一致顯示顯著療效（Kaufman 1998 n=1879 vertex +86 hairs/inch²、Leyden 1999 n=326 frontal +59 hairs/inch²、Whiting 2003 n=425 老年男性 +277 hairs/inch² @2y，全部 p<0.
B 🟡 B 初步證據 附警語發布 ⚠️ medium — moderate promotional content
Finasteride 1 mg/日治療男性雄性禿（AGA）為 S-tier 強證據：(1) 三項大型雙盲 RCT 一致顯示顯著療效（Kaufman 1998 n=1879 vertex +86 hairs/inch²、Leyden 1999 n=326 frontal +59 hairs/inch²、Whiting 2003 n=425 老年男性 +277 hairs/inch² @2y，全部 p<0.001）；(2) Mella 2010 MA n=3927 pooled MD +9.42 hairs/cm² (95% CI 7.20-11.65) 證實效應一致性；(3) 全球四大監管機構（FDA 1997、EMA、MHRA、TFDA）與四大主流機構/學會（Mayo、Cleveland、Harvard、AAD+ISHRS）一致認可為 FDA 核准之 first-line 男性 AGA 治療，AAD 明列為僅有兩種 FDA 核准 AGA 藥物之一，ISHRS Task Force 明確聲明『safe and effective treatment』。
男性 AGA 整體證據強度 = S-tier。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.66
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
80%
證據方向一致性高
證據層級
E3
單篇高品質統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.663
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Finasteride in the treatment of men with androgenetic alopecia (Propecia phase III pivotal)
結論：Significant increase in hair count vs placebo at week 48 and 96 (mean +86 hairs/inch² at 1y vs placebo loss); 83% of finasteride men had no further loss vs 28% placebo (p<0.001).
前往 PubMed
Finasteride in the treatment of men with frontal male pattern hair loss (Leyden 1999)
結論：Finasteride significantly improved frontal hair count vs placebo (mean +49.5 vs -9.6 hairs, p<0.001); investigator photographic assessment improved in 51% vs 7% placebo.
前往 PubMed
Efficacy and tolerability of finasteride 1 mg in men aged 41 to 60 years with male pattern hair loss (Whiting 2003)
結論：Finasteride sustained benefit over 2 years in older men: significantly higher hair counts and global assessment scores vs placebo (p<0.001); efficacy comparable to younger cohort.
前往 PubMed
Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review (Mella 2010)
結論：Pooled MD +9.42 hairs/cm² at 12 months in men (95% CI 7.20-11.65, p<0.001); investigator and patient ratings significantly improved; adverse-event risk small but elevated for sexual dysfunction (RR ~1.4).
前往 PubMed
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia (Price 2000)
結論：No significant difference between finasteride 1 mg and placebo on any endpoint in postmenopausal women with FPHL — null result.
前往 PubMed
Finasteride treatment of female pattern hair loss (Iorizzo 2006)
結論：62% of premenopausal women with FPHL showed clinical improvement on 2.5 mg finasteride + OC over 12 months; small open-label, no placebo arm.
前往 PubMed
L4a US FDA
支持
Sexual dysfunction that continued after discontinuation 來源↗
L4b EU EFSA
未表態
— 本適應症無對應資料
L4c UK NHS
謹慎
Finasteride and minoxidil are the main treatments for male pattern baldness. ... Finasteride and minoxidil are not available on the NHS. ... Both can have side effects, and they do not work for everyone. ... For benign prostate enlargement, finasteride and dutasteride are 5-alpha reductase inhibitors which block the hormones that cause the prostate to grow. 來源↗
L4d TW TFDA / 衛福部
謹慎
Finasteride（柔沛 Propecia 1mg、波斯卡 Proscar 5mg）為醫師處方用藥，仿單載明可能引起性功能障礙（性慾減退、勃起功能障礙、射精異常），部分症狀於停藥後仍可能持續。 來源↗
L4e WHO
謹慎
Finasteride has an established WHO International Nonproprietary Name (INN). It is NOT listed on the WHO Model List of Essential Medicines (24th edition, 2025); BPH/androgenetic alopecia treatments are generally outside EML scope. VigiBase (WHO global pharmacovigilance database, managed by UMC Uppsala) has accumulated disproportionality signals for sexual dysfunction associated with finasteride … 來源↗
L5a NIH Office of Dietary Supplements
未表態
— 本適應症無對應資料
L5b Mayo Clinic
支持
If you are taking this medicine for male pattern hair loss, it may take at least 3 months to see an effect. The medicine will not cure hair loss, but it will cause scalp hair to grow. The hair growth will only last as long as the medicine is used. The new hair will be lost within 1 year after the medicine is stopped. 來源↗
L5c Cleveland Clinic
支持
— 本適應症無對應資料
L5d Harvard Health
支持
Finasteride (Propecia) is an FDA-approved oral medication for male pattern hair loss that works by blocking the conversion of testosterone to dihydrotestosterone (DHT), the hormone that shrinks hair follicles in genetically susceptible men. In clinical trials, about 80% to 90% of men taking 1 mg daily either maintained or regrew hair, though benefit is lost within a year of stopping. Sexual sid… 來源↗
L5e Specialty Society (condition-mapped)
支持
The U.S. Food and Drug Administration (FDA) approved this medication to treat male pattern hair loss. When taken as directed, finasteride can: Slow down hair loss [and] Stimulate new hair growth. Finasteride is a pill that you take once a day. ... If finasteride works for you, you will need to keep taking it to continue getting results. Once you stop, you'll start losing hair again. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
PTT hair_loss / Pharmacy 與 Dcard 醫美/男性保養討論極熱絡。多數人認為非那雄胺（波斯卡/柔沛）對雄性禿有效但需長期、耐心服用，常見搭配落建（minoxidil）。最大爭議在性功能副作用與「非那雄胺後綜合徵（PFS）」是否真實，社群反應分歧。常見用法為波斯卡切四分之一（約1.25mg）以降低成本替代柔沛。
💬社群實感
分歧（多數認為有效但需長期耐心；少數反映無感或改用更強的適尿通 dutasteride）
破解迷思 社群最常見的 5 個誤解
✓
事實仿單上列出的副作用都很常見（實際多為「所有可能」而非典型，發生率約1-2%）
✓
事實吃幾天沒副作用就代表安全 / 出現症狀超過半衰期就是永久損傷（PFS 是否真實醫界仍有爭議）
✓
事實波斯卡（5mg）和柔沛（1mg）切劑量後療效有差（實際同為 finasteride，療效相近，差別在成本）
✓
事實停藥後頭髮可維持不掉（實際停藥毛囊會持續萎縮、落髮回復）
✓
事實劑量越高生髮效果越好（實際 1mg 已近最大效益，再加量只增副作用）
🩹 社群通報的副作用
- 性慾下降 / 勃起功能障礙 / 晨勃硬度下降
- 情緒低落 / 抑鬱
- 疲憊、健身力量下降、恢復變慢
- 體重增加 / 月亮臉、水腫感
- 頻尿 / 尿不盡
- 男性女乳症（gynecomastia）
- 認知模糊
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- 波斯卡 Proscar（finasteride 5mg，最常被切四分之一使用）
- 柔沛 Propecia（finasteride 1mg）
- 菲那諾 / 菲納諾（學名藥）
- 保康絲（學名藥）
- 適尿通 Avodart / dutasteride（常被當作更強替代品比較）
- 落建 / 洛寧錠 minoxidil（常搭配外用/口服）
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- 外用 Minoxidil（落健）
- 口服 Finasteride（柔沛）
- 低能量雷射治療（LLLT）
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-androgenetic-alopecia-INT-finasteride-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "非那雄胺能改善雄性禿（雄性激素性脫髮）",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}